Opioid receptor modulator dosage formulations | Patent Publication Number 20220008394

US 20220008394 A1
Patent NumberUS 11311516 B2
Application Number17481874
Filled DateSep 22, 2021
Priority DateMar 14, 2013
Publication DateJan 13, 2022
Original AssigneeAbbvie Inc.
Current AssigneeFuriex Holdings Unlimited Company
Inventor/ApplicantsEugeen Maria Jozef Jans
Philip Erna H. Heyns
Jens Jozef Ceulemans
Tim Costello
Philip Ema H. Heyns
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.